N-<2-(Dimethylamino)ethyl>-2-phenylquinolin-4-amine | 148726-12-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: N-<2-(Dimethylamino)ethyl>-2-phenylquinolin-4-amine
• 英文别名: N-<2-(dimethylamino)ethyl>-2-phenylquinoline；N,N-dimethyl-N'-(2-phenylquinolin-4-yl)ethane-1,2-diamine；dimethyl{2-[(2-phenyl(4-quinolyl))amino]ethyl}amine；MB1_C_006704A-3；MMV006704；N-[2-(dimethylamino)ethyl]-2-phenylquinolin-4-amine；1,2-Ethanediamine, N,N-dimethyl-N'-(2-phenyl-4-quinolinyl)-；N',N'-dimethyl-N-(2-phenylquinolin-4-yl)ethane-1,2-diamine
• CAS: 148726-12-9
• 化学式: C₁₉H₂₁N₃
• 分子量: 291.396
• InChiKey: QWAVSGXBYFASKZ-UHFFFAOYSA-N

物化性质

• 沸点：
  477.2±45.0 °C(Predicted)
• 密度：
  1.128±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  28.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  邻氨基三氟甲苯 在 lithium diisopropyl amide 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 生成 N-<2-(Dimethylamino)ethyl>-2-phenylquinolin-4-amine
  参考文献：
  名称：

  阴离子活化的三氟甲基的新型转化方法用于氟杂芳族化合物的非常规合成方法

  摘要：

  锂试剂从苯乙酮，苯乙炔衍生的，和取代的乙腈经历与2-（三氟甲基）苯胺（反应1），得到相应的4- fluoroquinolines 8，10A-d 。2-苯并[b]噻吩锂与2-（三氟甲基）苄基氯的相关反应（12）产生6-氟苯并[b]萘并[2，3-d]噻吩（17）。

  DOI：

  10.1016/s0040-4039(00)78352-3

文献信息

• Imaging agents for detecting neurological disorders
  申请人：Gangadharmath Umesh B.

  公开号：US20100239496A1

  公开（公告）日：2010-09-23

  Imaging agents of formula (I) and methods for detecting neurological disorders comprising administering to a patient in need compounds of formula (I) capable of binding to tau proteins and β-amyloid peptides are presented herein. The invention also relates to methods of imaging Aβ and tau aggregates comprising introducing a detectable quantity of pharmaceutical formulation comprising a radiolabeled compound of formula (I) and detecting the labeled compound associated with amyloid deposits and/or tau proteins in a patient. These methods and compositions enable preclinical diagnosis and monitoring progression of AD and other neurological disorders.

  本文提供了一种公式（I）的成像剂和检测神经系统疾病的方法，包括向需要的患者施用能够结合tau蛋白和β-淀粉样肽的公式（I）化合物。该发明还涉及成像Aβ和tau聚集物的方法，包括引入含有公式（I）放射标记化合物的制剂的可检测量，并检测与淀粉样沉积物和/或tau蛋白相关的标记化合物在患者体内的情况。这些方法和组合物使得能够进行临床前诊断和监测阿尔茨海默病和其他神经系统疾病的进展。
• Imaging Agents for Detecting Neurological Disorders
  申请人：Szardenings Anna Katrin

  公开号：US20110182812A1

  公开（公告）日：2011-07-28

  Imaging agents of formulas (I)-(V) and methods for detecting neurological disorders comprising administering to a patient in need compounds of formulas (I)-(V) capable of binding to tau proteins and β-amyloid peptides are presented herein. The invention also relates to methods of imaging Aβ and tau aggregates comprising introducing a detectable quantity of pharmaceutical formulation comprising a radiolabeled compound of formulas (I)-(V) and detecting the labeled compound associated with amyloid deposits and/or tau proteins in a patient. These methods and compositions enable preclinical diagnosis and monitoring progression of AD and other neurological disorders.

  本文介绍了公式（I）-（V）的成像剂和用于检测神经系统疾病的方法，其中包括向需要治疗的患者注射能够结合tau蛋白和β-淀粉样肽的公式（I）-（V）化合物。本发明还涉及成像Aβ和tau聚集物的方法，包括引入含有放射性标记的公式（I）-（V）化合物的制剂，并检测与淀粉样沉积物和/或tau蛋白相关联的标记化合物。这些方法和组合物可用于预临床诊断和监测AD和其他神经系统疾病的进展。
• Quinolines derivatives as novel anticancer agents
  申请人：GENOSCIENCE PHARMA

  公开号：US10179770B2

  公开（公告）日：2019-01-15

  The invention provides quinoline derivatives, their manufacture, pharmaceutical compositions containing them, and their use as medicaments. The active compounds of the present invention are useful for the treatment of proliferative neoplastic and non-neoplastic diseases.

  本发明提供了喹啉衍生物、喹啉衍生物的制造、含有喹啉衍生物的药物组合物以及喹啉衍生物作为药物的用途。本发明的活性化合物可用于治疗增殖性肿瘤和非肿瘤疾病。
• Synthesis and quantitative structure-activity relationship analysis of 2-(aryl or heteroaryl)quinolin-4-amines, a new class of anti-HIV-1 agents
  作者：Lucjan Strekowski、Jerzy L. Mokrosz、Vidya A. Honkan、Agnieszka Czarny、Marek T. Cegla、Roman L. Wydra、Steven E. Patterson、Raymond F. Schinazi

  DOI：10.1021/jm00109a031

  日期：1991.5

  Thirty-eight 2-(aryl or heteroaryl)quinolin-4-amines, N,N-disubstituted, N-monosubstituted, and without a substituent at the amino group have been synthesized with use of novel chemistries developed by us recently. Some of these derivatives show anti-HIV-1 activity at a concentration level of 1-mu-M and low cell toxicity in vitro. The most active and least toxic compounds are derivatives of 2-(3-pyridyl)quinoline. The results of the quantitative structure-activity relationship analyses, including several classical, linear regression correlations and a Free-Wilson approach, of de novo model, provide guidelines for the design of new active compounds of this class.
• Further studies on the cyclization of aromatic azomethines ortho-substituted with a trifluoromethyl group: synthesis of 2,4-di- or 2,3,4-trisubstituted quinolines
  作者：Lucjan Strekowski、Steven E. Patterson、Lubomir Janda、Roman L. Wydra、Donald B. Harden、Malgorzata Lipowska、Marek T. Cegla

  DOI：10.1021/jo00027a037

  日期：1992.1

  The scope and limitations of the novel synthetic route to quinolines (Strekowski et al. J. Org. Chem. 1990, 55, 4777) have been studied. A direct condensation of 2-(trifluoromethyl)aniline (1) with methyl aryl ketones, methyl heteroaryl ketones, ethyl aryl ketones, methyl vinyl ketones, 1-indanone, 1-tetralone, camphor, and cyclohexanone provides an easy access to the corresponding ketimines. An indirect one-pot preparation of dialkyl ketimines and C-alkyl-substituted amidines derived from 1, but inaccessible by the direct condensation method, is also presented. All these ketimines and amidines are cyclized in the presence of alkylamide, dialkylamide, or alkoxide bases to give a quinoline containing the base function at C-4. Analysis of byproducts of the base-mediated reactions provides strong support for the originally proposed mechanism of the quinoline formation.